Viewing Study NCT02261220


Ignite Creation Date: 2025-12-25 @ 4:16 AM
Ignite Modification Date: 2026-02-02 @ 3:41 AM
Study NCT ID: NCT02261220
Status: COMPLETED
Last Update Posted: 2020-03-06
First Post: 2014-10-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors
Sponsor: MedImmune LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced solid tumors View
None durvalumab View
None tremelimumab View